OTLK logo

Outlook Therapeutics (OTLK) Current Liabilities

Annual Current Liabilities

$46.73 M
+$27.00 M+136.86%

30 September 2023

OTLK Current Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Current Liabilities

$42.55 M
-$11.53 M-21.31%

30 June 2024

OTLK Quarterly Current Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

OTLK Current Liabilities Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year--8.9%
3 y3 years+592.1%+530.2%
5 y5 years+130.3%+109.7%

OTLK Current Liabilities High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 yearsat high+592.1%-21.3%+530.2%
5 y5 yearsat high+592.1%-21.3%+530.2%
alltimeall timeat high+592.1%-21.3%+530.2%

Outlook Therapeutics Current Liabilities History

DateAnnualQuarterly
June 2024
-
$42.55 M(-21.3%)
Mar 2024
-
$54.08 M(+17.6%)
Dec 2023
-
$45.97 M(-1.6%)
Sept 2023
$46.73 M(+136.9%)
$46.73 M(-6.4%)
June 2023
-
$49.93 M(+14.7%)
Mar 2023
-
$43.53 M(+188.6%)
Dec 2022
-
$15.08 M(-23.6%)
Sept 2022
$19.73 M(+192.2%)
$19.73 M(+7.1%)
June 2022
-
$18.43 M(-41.3%)
Mar 2022
-
$31.41 M(+57.5%)
Dec 2021
-
$19.95 M(+195.4%)
Sept 2021
$6.75 M(-57.5%)
$6.75 M(-65.6%)
June 2021
-
$19.64 M(-17.8%)
Mar 2021
-
$23.90 M(+97.1%)
Dec 2020
-
$12.12 M(-23.7%)
Sept 2020
$15.89 M
$15.89 M(-13.9%)
June 2020
-
$18.45 M(-22.2%)
Mar 2020
-
$23.71 M(+17.9%)
DateAnnualQuarterly
Dec 2019
-
$20.10 M(-0.9%)
Sept 2019
$20.29 M(-36.7%)
$20.29 M(-12.6%)
June 2019
-
$23.22 M(-14.0%)
Mar 2019
-
$26.99 M(-2.0%)
Dec 2018
-
$27.54 M(-14.1%)
Sept 2018
$32.04 M(+11.5%)
$32.04 M(-0.7%)
June 2018
-
$32.26 M(+1.6%)
Mar 2018
-
$31.75 M(+1.8%)
Dec 2017
-
$31.20 M(+8.6%)
Sept 2017
$28.74 M(+40.6%)
$28.74 M(-26.8%)
June 2017
-
$39.27 M(+12.9%)
Mar 2017
-
$34.78 M(+8.2%)
Dec 2016
-
$32.13 M(+57.2%)
Sept 2016
$20.44 M(-44.8%)
$20.44 M(-10.9%)
June 2016
-
$22.94 M(-36.2%)
Mar 2016
-
$35.98 M(+0.6%)
Dec 2015
-
$35.76 M(-3.5%)
Sept 2015
$37.04 M(0.0%)
$37.04 M
Sept 2014
$37.04 M
-

FAQ

  • What is Outlook Therapeutics annual total current liabilities?
  • What is the all time high annual current liabilities for Outlook Therapeutics?
  • What is Outlook Therapeutics quarterly total current liabilities?
  • What is the all time high quarterly current liabilities for Outlook Therapeutics?
  • What is Outlook Therapeutics quarterly current liabilities year-on-year change?

What is Outlook Therapeutics annual total current liabilities?

The current annual current liabilities of OTLK is $46.73 M

What is the all time high annual current liabilities for Outlook Therapeutics?

Outlook Therapeutics all-time high annual total current liabilities is $46.73 M

What is Outlook Therapeutics quarterly total current liabilities?

The current quarterly current liabilities of OTLK is $42.55 M

What is the all time high quarterly current liabilities for Outlook Therapeutics?

Outlook Therapeutics all-time high quarterly total current liabilities is $54.08 M

What is Outlook Therapeutics quarterly current liabilities year-on-year change?

Over the past year, OTLK quarterly total current liabilities has changed by -$4.18 M (-8.94%)